The CD8 T-cell clone shows cytotoxicity against tumours expressing XAGE-1b and the appropriate HLA class I allele, suggesting that XAGE-1b is an ideal target for a lung cancer vaccine and therapy (102, 103). This evidence concerns the gene XAGE1B and lung carcinoma.